SBRVX
Price
$15.38
Change
-$0.20 (-1.28%)
Updated
Sep 20 closing price
VSCPX
Price
$326.54
Change
-$2.23 (-0.68%)
Updated
Sep 20 closing price
Ad is loading...

SBRVX vs VSCPX

Header iconSBRVX vs VSCPX Comparison
Open Charts SBRVX vs VSCPXBanner chart's image
Segall Bryant & Hamill Sm Cp Val Ret
Price$15.38
Change-$0.20 (-1.28%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Index InstlPlus
Price$326.54
Change-$2.23 (-0.68%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
SBRVX vs VSCPX Comparison Chart
Loading...
VS
SBRVX vs. VSCPX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SBRVX is a StrongBuy and VSCPX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VSCPX has more cash in the bank: 149B vs. SBRVX (511M). VSCPX pays higher dividends than SBRVX: VSCPX (1.44) vs SBRVX (1.19). SBRVX was incepted earlier than VSCPX: SBRVX (5 years) vs VSCPX (14 years). SBRVX is a more actively managed with annual turnover of: 35.00 vs. VSCPX (12.00). SBRVX has a lower initial minimum investment than VSCPX: SBRVX (2500) vs VSCPX (100000000). VSCPX annual gain was more profitable for investors over the last year : 25.55 vs. SBRVX (22.03).
SBRVXVSCPXSBRVX / VSCPX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence5 years14 years-
Gain YTD11.36910.906104%
Front LoadN/AN/A-
Min. Initial Investment25001000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets511M149B0%
Annual Yield % from dividends1.191.4483%
Returns for 1 year22.0325.5586%
Returns for 3 years9.098.92102%
Returns for 5 yearsN/A53.49-
Returns for 10 yearsN/A121.69-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSCO274.920.95
+0.35%
Tractor Supply Company
SGH19.70-0.10
-0.51%
SMART Global Holdings
PBPB8.23-0.11
-1.38%
Potbelly Corp
AVNT48.10-0.87
-1.78%
Avient Corp
CUE0.52-0.04
-7.26%
Cue Biopharma